Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.
Latest Information Update: 16 Apr 2024
At a glance
- Drugs Esflurbiprofen (Primary)
- Indications Acute pain
- Focus Therapeutic Use
- Sponsors Teikoku Seiyaku
Most Recent Events
- 11 Apr 2024 Status changed from not yet recruiting to completed.
- 20 Sep 2023 New trial record